Anthem, Inc. (NASDAQ:ANTX - Get Free Report)'s share price passed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $4.24 and traded as high as $5.32. Anthem shares last traded at $4.95, with a volume of 967,391 shares traded.
Analyst Ratings Changes
Separately, Weiss Ratings restated a "sell (d-)" rating on shares of Anthem in a research report on Friday, October 2nd. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $9.00.
View Our Latest Research Report on Anthem
Anthem Trading Up 17.0%
The stock's fifty day moving average is $4.53 and its 200 day moving average is $4.24. The company has a market capitalization of $187.80 million, a P/E ratio of -5.32 and a beta of -0.93.
Anthem (NASDAQ:ANTX - Get Free Report) last announced its quarterly earnings results on Monday, November 9th. The company reported ($0.17) earnings per share (EPS) for the quarter.
Insider Buying and Selling at Anthem
In related news, Director Robin Shane Readnour sold 10,019 shares of the firm's stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $6.02, for a total value of $60,314.38. Following the sale, the director directly owned 557,990 shares of the company's stock, valued at $3,359,099.80. This trade represents a 1.76% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders have sold 20,325 shares of company stock worth $117,441 in the last ninety days. Corporate insiders own 22.61% of the company's stock.
Institutional Investors Weigh In On Anthem
Several institutional investors and hedge funds have recently bought and sold shares of the business. Algert Global LLC bought a new stake in shares of Anthem in the 3rd quarter worth approximately $63,000. Goldman Sachs Group Inc. increased its stake in shares of Anthem by 621.7% during the third quarter. Goldman Sachs Group Inc. now owns 634,655 shares of the company's stock valued at $3,376,000 after buying an additional 546,722 shares during the period. Toronto Dominion Bank bought a new position in shares of Anthem during the third quarter valued at approximately $415,000. Marshall Wace LLP bought a new position in shares of Anthem during the third quarter valued at approximately $565,000. Finally, Empowered Funds LLC bought a new position in shares of Anthem during the third quarter valued at approximately $309,000. Hedge funds and other institutional investors own 90.47% of the company's stock.
About Anthem
(
Get Free Report)
Anthem, Inc. was a U.S. health benefits company that provided health insurance and related services to individuals, employers, and government-sponsored programs. Its offerings included medical, dental, and vision coverage, pharmacy benefits, and plans serving Medicare and Medicaid members. The company operated health plans across the United States, including plans affiliated with the Blue Cross Blue Shield network. In 2022, Anthem changed its corporate name to Elevance Health to reflect a broader focus on health services beyond insurance.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Anthem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anthem wasn't on the list.
While Anthem currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.